Telmisatran EP Impurity C is a structurally related byproduct arising from the synthetic pathway of Telmisatran, characterized by a substituted tetrazole ring conjugated to a biphenyl moiety with a methoxy group at the para position. Its core scaffold retains the 2,4-dichlorobenzoyl functionality of the parent compound but features an additional ethyl ester linkage at the terminal carboxylic acid, distinguishing it as a partial hydrolysis intermediate. This impurity exhibits a planar conformation due to extended aromatic conjugation, enhancing its chromatographic retention profile. It serves as a critical HPLC reference standard for quantifying process-related impurities in Telmisatran drug substance analysis.
On Request| Std | Catalog # | Quantity | Price |
|---|---|---|---|
| USP | 1A08730 โ | 25 mg | USD 895.00 |
CCCC1=NC2=C(N1CC3=CC=C(C=C3)C4=CC=CC=C4C(=O)OC(C)(C)C)C=C(C=C2C)C5=NC6=CC=CC=C6N5C
InChI=1S/C37H38N4O2/c1-7-12-33-39-34-24(2)21-27(35-38-30-15-10-11-16-31(30)40(35)6)22-32(34)41(33)23-25-17-19-26(20-18-25)28-13-8-9-14-29(28)36(42)43-37(3,4)5/h8-11,13-22H,7,12,23H2,1-6H3
JSCFLEBEWCTASN-UHFFFAOYSA-N